|
A new short textbook of microbial and parasitic infection |
||||
APA | (1987). A new short textbook of microbial and parasitic infection, Kent: ELBS. | ||||
MLA | A new short textbook of microbial and parasitic infection. Kent: ELBS, 1987. | ||||
Harvard | 1987. A new short textbook of microbial and parasitic infection. ELBS, | ||||
Chicago | A new short textbook of microbial and parasitic infection. ELBS, 1987. | ||||
|
Infection control [videorecording] |
||||
APA | (2007). Infection control [videorecording], New York : In Service Monthly, Inc.. | ||||
MLA | Infection control [videorecording]. New York : In Service Monthly, Inc., 2007. | ||||
Harvard | 2007. Infection control [videorecording]. In Service Monthly, Inc., | ||||
Chicago | Infection control [videorecording]. In Service Monthly, Inc., 2007. | ||||
|
Essential microbiology for pharmacy and pharmaceutical science |
||||
APA | (2013). Essential microbiology for pharmacy and pharmaceutical science, Chichester, West Sussex, UK: Willey-Blackwell. | ||||
MLA | Essential microbiology for pharmacy and pharmaceutical science. Chichester, West Sussex, UK: Willey-Blackwell, 2013. | ||||
Harvard | 2013. Essential microbiology for pharmacy and pharmaceutical science. Willey-Blackwell, | ||||
Chicago | Essential microbiology for pharmacy and pharmaceutical science. Willey-Blackwell, 2013. | ||||
|
Evaluation of six commercial products for colistin susceptibility testing in Enterobacterales |
||||
APA | Evaluation of six commercial products for colistin susceptibility testing in Enterobacterales. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Evaluation of six commercial products for colistin susceptibility testing in Enterobacterales". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Evaluation of six commercial products for colistin susceptibility testing in Enterobacterales. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Evaluation of six commercial products for colistin susceptibility testing in Enterobacterales" CMI : clinical microbiology and infection, (): . | ||||
|
Chronic Q fever-related complications and mortality: data from a nationwide cohort |
||||
APA | Chronic Q fever-related complications and mortality: data from a nationwide cohort. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Chronic Q fever-related complications and mortality: data from a nationwide cohort". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Chronic Q fever-related complications and mortality: data from a nationwide cohort. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Chronic Q fever-related complications and mortality: data from a nationwide cohort" CMI : clinical microbiology and infection, (): . | ||||
|
Microbiological diagnostics of bloodstream infections in Europe—an ESGBIES survey |
||||
APA | Microbiological diagnostics of bloodstream infections in Europe—an ESGBIES survey. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Microbiological diagnostics of bloodstream infections in Europe—an ESGBIES survey". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Microbiological diagnostics of bloodstream infections in Europe—an ESGBIES survey. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Microbiological diagnostics of bloodstream infections in Europe—an ESGBIES survey" CMI : clinical microbiology and infection, (): . | ||||
|
Risk factors for community-onset bloodstream infection with extended-spectrum ß-lactamase-producing Enterobacteriaceae: national population-based case–control study |
||||
APA | Risk factors for community-onset bloodstream infection with extended-spectrum ß-lactamase-producing Enterobacteriaceae: national population-based case–control study. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Risk factors for community-onset bloodstream infection with extended-spectrum ß-lactamase-producing Enterobacteriaceae: national population-based case–control study". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Risk factors for community-onset bloodstream infection with extended-spectrum ß-lactamase-producing Enterobacteriaceae: national population-based case–control study. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Risk factors for community-onset bloodstream infection with extended-spectrum ß-lactamase-producing Enterobacteriaceae: national population-based case–control study" CMI : clinical microbiology and infection, (): . | ||||
|
Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical trial |
||||
APA | Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical trial. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical trial". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical trial. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical trial" CMI : clinical microbiology and infection, (): . | ||||
|
Long-term immunogenicity and immune persistence of live attenuated and inactivated hepatitis a vaccines: a report on additional observations from a phase IV study |
||||
APA | Long-term immunogenicity and immune persistence of live attenuated and inactivated hepatitis a vaccines: a report on additional observations from a phase IV study. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Long-term immunogenicity and immune persistence of live attenuated and inactivated hepatitis a vaccines: a report on additional observations from a phase IV study". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Long-term immunogenicity and immune persistence of live attenuated and inactivated hepatitis a vaccines: a report on additional observations from a phase IV study. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Long-term immunogenicity and immune persistence of live attenuated and inactivated hepatitis a vaccines: a report on additional observations from a phase IV study" CMI : clinical microbiology and infection, (): . | ||||
|
Enteropathogens in paediatric gastroenteritis: comparison of routine diagnostic and molecular methods |
||||
APA | Enteropathogens in paediatric gastroenteritis: comparison of routine diagnostic and molecular methods. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Enteropathogens in paediatric gastroenteritis: comparison of routine diagnostic and molecular methods". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Enteropathogens in paediatric gastroenteritis: comparison of routine diagnostic and molecular methods. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Enteropathogens in paediatric gastroenteritis: comparison of routine diagnostic and molecular methods" CMI : clinical microbiology and infection, (): . | ||||
|
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study |
||||
APA | The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study. CMI : clinical microbiology and infection , , . | ||||
MLA | . "The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study". CMI : clinical microbiology and infection : . | ||||
Harvard | , . The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study" CMI : clinical microbiology and infection, (): . | ||||
|
Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection |
||||
APA | Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection" CMI : clinical microbiology and infection, (): . | ||||
|
Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study |
||||
APA | Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study" CMI : clinical microbiology and infection, (): . | ||||
|
Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex |
||||
APA | Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex" CMI : clinical microbiology and infection, (): . | ||||
|
An automated smear microscopy system to diagnose tuberculosis in a high-burden setting |
||||
APA | An automated smear microscopy system to diagnose tuberculosis in a high-burden setting. CMI : clinical microbiology and infection , , . | ||||
MLA | . "An automated smear microscopy system to diagnose tuberculosis in a high-burden setting". CMI : clinical microbiology and infection : . | ||||
Harvard | , . An automated smear microscopy system to diagnose tuberculosis in a high-burden setting. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "An automated smear microscopy system to diagnose tuberculosis in a high-burden setting" CMI : clinical microbiology and infection, (): . | ||||
|
Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trial |
||||
APA | Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trial. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trial". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trial. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trial" CMI : clinical microbiology and infection, (): . | ||||
|
Molecular diagnosis of polymicrobial brain abscesses with 16S-rDNA-based next-generation sequencing |
||||
APA | Molecular diagnosis of polymicrobial brain abscesses with 16S-rDNA-based next-generation sequencing. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Molecular diagnosis of polymicrobial brain abscesses with 16S-rDNA-based next-generation sequencing". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Molecular diagnosis of polymicrobial brain abscesses with 16S-rDNA-based next-generation sequencing. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Molecular diagnosis of polymicrobial brain abscesses with 16S-rDNA-based next-generation sequencing" CMI : clinical microbiology and infection, (): . | ||||
|
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study |
||||
APA | Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study" CMI : clinical microbiology and infection, (): . | ||||
|
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study |
||||
APA | Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study" CMI : clinical microbiology and infection, (): . | ||||
|
Lower respiratory tract infection in the community: associations between viral aetiology and illness course |
||||
APA | Lower respiratory tract infection in the community: associations between viral aetiology and illness course. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Lower respiratory tract infection in the community: associations between viral aetiology and illness course". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Lower respiratory tract infection in the community: associations between viral aetiology and illness course. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Lower respiratory tract infection in the community: associations between viral aetiology and illness course" CMI : clinical microbiology and infection, (): . | ||||
|
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study |
||||
APA | Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study" CMI : clinical microbiology and infection, (): . | ||||
|
Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19 |
||||
APA | Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19" CMI : clinical microbiology and infection, (): . | ||||
|
National case fatality rates of the COVID-19 pandemic |
||||
APA | National case fatality rates of the COVID-19 pandemic. CMI : clinical microbiology and infection , , . | ||||
MLA | . "National case fatality rates of the COVID-19 pandemic". CMI : clinical microbiology and infection : . | ||||
Harvard | , . National case fatality rates of the COVID-19 pandemic. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "National case fatality rates of the COVID-19 pandemic" CMI : clinical microbiology and infection, (): . | ||||
|
Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial |
||||
APA | Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial" CMI : clinical microbiology and infection, (): . | ||||
|
Diagnostic accuracy of droplet digital PCR analysis of cerebrospinal fluid for tuberculous meningitis in adult patients |
||||
APA | Diagnostic accuracy of droplet digital PCR analysis of cerebrospinal fluid for tuberculous meningitis in adult patients. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Diagnostic accuracy of droplet digital PCR analysis of cerebrospinal fluid for tuberculous meningitis in adult patients". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Diagnostic accuracy of droplet digital PCR analysis of cerebrospinal fluid for tuberculous meningitis in adult patients. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Diagnostic accuracy of droplet digital PCR analysis of cerebrospinal fluid for tuberculous meningitis in adult patients" CMI : clinical microbiology and infection, (): . | ||||
|
Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes |
||||
APA | Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes" CMI : clinical microbiology and infection, (): . | ||||
|
Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients |
||||
APA | Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients" CMI : clinical microbiology and infection, (): . | ||||
|
Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018 |
||||
APA | Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018" CMI : clinical microbiology and infection, (): . | ||||
|
Are nontreponemal tests suitable for monitoring syphilis treatment efficacy? Evidence from rabbit infection models |
||||
APA | Are nontreponemal tests suitable for monitoring syphilis treatment efficacy? Evidence from rabbit infection models. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Are nontreponemal tests suitable for monitoring syphilis treatment efficacy? Evidence from rabbit infection models ". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Are nontreponemal tests suitable for monitoring syphilis treatment efficacy? Evidence from rabbit infection models. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Are nontreponemal tests suitable for monitoring syphilis treatment efficacy? Evidence from rabbit infection models" CMI : clinical microbiology and infection, (): . | ||||
|
Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis |
||||
APA | Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis. CMI : clinical microbiology and infection , , . | ||||
MLA | . "Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis". CMI : clinical microbiology and infection : . | ||||
Harvard | , . Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis. CMI : clinical microbiology and infection, , . | ||||
Chicago | . "Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis" CMI : clinical microbiology and infection, (): . |